The Influence of Diagnosis Intervention Packet Policy Intervention on Medication Structure and Drug Cost of Elderly Hypertensive Inpatients in China: A Multicenter Interrupted Time-Series Analysis
Dongsheng Hong,Duo Lv,Jiaying Wu,Xin Li,Qingwei Zhao,Xiaoyang Lu,Lu Li
DOI: https://doi.org/10.2147/RMHP.S418541
2023-09-09
Risk Management and Healthcare Policy
Abstract:Dongsheng Hong, 1, 2 Duo Lv, 1 Jiaying Wu, 1 Xin Li, 1 Qingwei Zhao, 1 Xiaoyang Lu, 1 Lu Li 2 1 Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China; 2 Department of Social Medicine of school of Public Health, Zhejiang University School of Medicine, Hangzhou, People's Republic of China Correspondence: Xiaoyang Lu, Key Laboratory for Drug Evaluation and Clinical Research of Zhejiang Province, the First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, People's Republic of China, Email Lu Li, Department of Social Medicine of school of Public Health, Zhejiang University School of Medicine, 866 Yuhangtang Road, Hangzhou, 310058, People's Republic of China, Email Background: DIP is a new medical insurance payment system developed in China which was implemented in Guangzhou in January 2018, but few studies have focused on its intervention effect on the drug burden of elderly hypertensive patients. Methods: Nine medical institutions in Guangzhou, China, were selected, among which, daily full medical orders of elderly hypertensive inpatients from 2016 to 2020 were randomly collected. To assess the impact of DIP policy intervention on patient drug burden, we took the data after policy implementation in January 2018, as the intervention data, and applied a segmented regression model with interrupted time series to analyze the trend and changes in average daily drug costs per month and medication structure, stratified by age, sex, and inpatient department. Results: A total of 34,276 elderly hypertensive patients' daily full medical orders were obtained. The immediate level change of drug costs after intervention was − 23.884 RMB/month ( P = 0.652), and the trend change was statistically significant (− 15.642 RMB/month, P = 0.002). The relative cumulative effect at the end of the study was − 78.860% (95% CI: − 86.087% to − 69.076%), and the intervention effect was more significant in surgical and male patients. The analysis of drug structure changes showed that after the implementation of the DIP policy intervention, the proportion of anti-infective drugs, anti-tumor drugs, and biological products all showed a significant downward trend ( P < 0.05), while nutritional drugs showed a significant upward trend ( P = 0.011), but no immediate horizontal change in slope was observed. Conclusion: The typical practice in China showed that DIP policy intervention can improve the drug burden of elderly hypertensive hospitalized patients and has a stable long-term effect, and the intervention effect is not consistent across different clinical department and populations with different characteristics, and it would also cause changes in the medication structure. Keywords: diagnosis-intervention packet policy, daily drug cost, interrupted time series analysis, elderly hypertension, medication structure The aging of the population and the increasing social demand for medical resources have caused the rapid growth of medical expenses in China. 1,2 To control the unreasonable growth of medical expenses, the Chinese government is promoting the reform of multiple and compound medical insurance payment modes. Among them, Big Data Diagnosis-Intervention Packet (DIP) policy intervention, 3 as original medical insurance payment mode, has been extensively piloted in many regions of China. With the continuous promotion of DIP policy, it can be predicted that shortly, China's DIP policy will have an impact on the medical expenditure of hundreds of millions of inpatients. 4 Previous studies have found that DIP policy has a positive effect on reducing the medical expenditure but mainly focusses on the total cost of inpatients. 5,6 With the drug zero addition reform promoted in recent years, drug costs have become a huge cost burden for hospitals under the DIP policy. There are few studies that rigorously evaluate the effects of the DIP policy on the changes in drug expenditure and medication structure. The other hand, the elderly hypertensive population has become one of the largest chronic patient populations in China, and the prevalence of hypertension among the elderly over 60 years old in China has exceeded 50%. 7 Elderly patients with hypertension as a special group, often accompanied by a variety of diseases, increased access to a variety of drug treatment after hospitalization. With the aging of the population, the hospitalization burden of elderly hypertensive patients will increase further.< -Abstract Truncated-
health care sciences & services,health policy & services